The global aneurysmal subarachnoid hemorrhage (SAH) treatment market is experiencing significant growth in the coming years. This increase can be attributed to several factors, such as a rising incidence of SAH globally, growing healthcare expenditure, and advancements in treatment modalities. The market is divided by various factors, like treatme